Hutch News

Hutch News

Stories tagged 'Sunil Hingorani'

Good News at Fred Hutch

Celebrating faculty and staff achievements

June 29, 2017

Dr. Amanda Paulovich of Fred Hutch has been selected to lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer.

View story >


Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

June 4, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >


Hutch News

Nov. 21, 2016

Stories include: world-renowned oncologist recruited to Fred Hutch, lymphoma patients in remission after experimental immunotherapy and more.

View story >


A new model for pancreatic cancer clinical research

Flexible, precision-medicine trial ‘driven by doing what is best for the individual patient’

Oct. 4, 2016 | By Susan Keown / Fred Hutch News Service

Called “Precision Promise,” this new nationwide precision-medicine trial in pancreatic cancer seeks to turn the concept of clinical trials on its head: Rather than finding participants for a given experimental treatment study, the approach finds the right treatment for a given patient at a given time.

View story >


Pancreatic tumors under pressure

The blood vessel-crushing, chemo-blocking pressure inside pancreatic tumors is almost entirely due to water trapped in gel form, study shows

May 10, 2016 | By Sabrina Richards / Fred Hutch News Service

The blood vessel-crushing, chemo-blocking pressure inside pancreatic tumors is almost entirely due to water trapped in gel form, a new study shows.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 4, 2016 | By Fred Hutch News Service staff

Drs. Marie Bleakley and Soheil Meshinchi receive $1M to design targeted immunotherapies for childhood leukemia; pancreatic cancer treatment advancing in clinical trials; novel mathematical model could transform dosage selection for clinical trials; new global initiative for breast cancer has roots in Seattle; Dr. Colin Correnti speaks at inaugural SHIFT 2016

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.